Acute lymphocytic leukemia, or ALL, is a rare type of blood cancer that impacts lymphocytes, a kind of white blood cell. While ALL can occur in individuals of any age, it is more prevalent in children under 15 and adults over 50. There are two main types of ALL, based on the type of blood cells involved - B-cell ALL and T-cell ALL. B-cell ALL, which constitutes 75% to 80% of cases, affects B-cells that produce antibodies and help combat infections. T-cell ALL, on the other hand, targets T-cells that eliminate pathogens and assist other immune system cells.
The stock we are bringing to your attention today is that of Autolus Therapeutics plc (AUTL), which is currently awaiting an FDA decision next month for its B-lymphocyte antigen CD19 (CD19) chimeric antigen receptor (CAR) T cell investigational therapy.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.